From organelle contact-site proteomics and signaling dynamics to astrocyte profiling and target discovery, Syncell delivers unmatched, end-to-end nanoscopic proteomics with spatial precision.
We use our state-of-the-art Microscoop Platform and Synlight reagents to achieve the highest resolution spatial proteomics purification and analysis method with extremely high sensitivity. Our team will work with you to understand your specific project needs and provide end-to-end services, from sample to protein discovery, delivering true biological insights. Powered by the same team that invented the technology, our offering is designed for researchers who demand unbiased proteomic insights.
Syncell is a specialized discovery partner focused on providing scientists with nanoscopic proteomics insights to enable more confident and actionable research. Our services go beyond data generation—we deliver decision-ready biological insight that informs prioritization, reduces risk, and accelerates programs.
Key Capabilities
Baseline proteomic signature for one region/condition. Ideal for: early target or pathway exploration.
Contrast proteomes across conditions (e.g., treated vs control). Ideal for: hypothesis testing & mechanistic understanding.
Multi-study engagements with strategic design and ongoing scientific collaboration.
Syncell operates like a niche discovery CRO—with deep domain expertise and a streamlined workflow designed for clarity and action:
✔ Collaborative study design
✔ In-process quality checks
✔ High-precision data generation
✔ Statistical rigor for confident decisions
This is not a self-service platform—it’s a partnership with experts who understand how proteomics drives discovery.
To focus on studies with true discovery impact, Syncell engages on projects that meet the following minimums:
These criteria ensure statistically informative data and meaningful insight for your program.
Syncell Discovery Services help research teams uncover biology not accessible with conventional proteomics—revealing novel protein patterns, mechanistic detail, and biomarker candidates that guide better decisions without building internal infrastructure.
